P2 Capital Partners, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001406313

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q4 2024 · 11 positions · Total reported value $588.77M · Top-10 concentration 97.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 53.3% · 3 new · 4 cut · 1 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +14.5% · vs SPY +12.3% · Prev Value $245.57M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.1% · vs SPY +2.0% · Latest Value $299.37M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, P2 Capital Partners, LLC disclosed 11 equity positions with a combined reported value of $588.77M. The filing implies a focused portfolio: its ten largest positions account for 97.5% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q4 2024 were CBZ ($148.03M), ACHC ($87.00M), JBTM ($75.44M). By sector, the heaviest allocations are Industrials 28.7%, Health Care 28.1%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+10.8pp) and away from Other (-0.5pp), Health Care (-2.9pp).

Versus the prior quarter, P2 Capital Partners, LLC opened 3 new positions, trimmed 4 and fully exited 1, a turnover rate of 53.3% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q4 2024 were HSIC ($40.37M).

Of the 1 positions fully exited versus the prior quarter, the largest were OPCH ($60.88M), MIR ($37.08M), ENSG ($33.08M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • HSIC SCHEIN HENRY INC · $40.37M

Fully Exited (vs previous quarter)

  • OPCH OPTION CARE HEALTH INC · prev qtr: $60.88M
  • MIR MIRION TECHNOLOGIES INC · prev qtr: $37.08M
  • ENSG ENSIGN GROUP INC · prev qtr: $33.08M
  • SITE SITEONE LANDSCAPE SUPPLY INC · prev qtr: $4.62M
  • SHC SOTERA HEALTH CO · prev qtr: $3.34M

Insider Transactions (Form 4)

Latest P2 Capital Partners, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

P2 Capital Partners, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 12 positions worth $245.57M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-73830 (status: Approved), registered 2012-03-30
  • Regulatory AUM (Form ADV): $824.40M as of 2026-04-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: p2capital.com

Portfolio Structure

  • 12 positions · $245.57M reported value (Q2 2026)
  • Top 10 holdings = 96.7% of reported value
  • Largest position: ACHC (ACADIA HEALTHCARE COMPANY INC COM) at 21.3%
  • Average position size: $20.46M

Sector Tilt

  • Health Care 40.7%
  • Industrials 21.3%
  • Consumer Discretionary 14.9%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 new, 1 added, 4 reduced
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Industrials 28.7%
Health Care 28.1%
Technology 9.5%
Other 8.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.81M $148.03M 25.14%
25.14%
Hold
2 2.19M $87.00M 14.78%
14.78%
Add
3 593.56K $75.44M 12.81%
12.81%
Reduce
4 758.18K $56.04M 9.52%
9.52%
Reduce
5 4.81M $50.22M 8.53%
8.53%
Reduce
6 517.08K $42.16M 7.16%
7.16%
Reduce
7 583.32K $40.37M 6.86%
6.86%
New
8 696.87K $28.47M 4.84%
4.84%
Reduce
9 510.80K $23.66M 4.02%
4.02%
Reduce
10 339.44K $22.91M 3.89%
3.89%
Reduce
11 330.00K $14.48M 2.46%
2.46%
Reduce

FAQ

What did P2 Capital Partners, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, P2 Capital Partners, LLC reported 11 equity positions worth $588.77M in aggregate; its largest disclosed positions were CBZ ($148.03M), ACHC ($87.00M), JBTM ($75.44M).

How large is P2 Capital Partners, LLC's portfolio?

P2 Capital Partners, LLC reported $588.77M of long equity holdings across 11 positions as of 2024-Q4. Top-10 holdings account for 97.5% of reported value.

What is P2 Capital Partners, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/p2-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →